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Serine catabolism to glycine and a one-carbon unit has been linked to the anabolic requirements of proliferat-
ing mammalian cells. However, genome-scale modeling predicts a catabolic role with one-carbon release as
formate. We experimentally prove that in cultured cancer cells and nontransformed fibroblasts, most of the
serine-derived one-carbon units are released from cells as formate, and that formate release is dependent on
mitochondrial reverse 10-CHO-THF synthetase activity. We also show that in cancer cells, formate release is
coupled to mitochondrial complex I activity, whereas in nontransformed fibroblasts, it is partially insensitive
to inhibition of complex I activity. We demonstrate that in mice, about 50% of plasma formate is derived from
serine and that serine starvation or complex I inhibition reduces formate synthesis in vivo. These observations
transform our understanding of one-carbon metabolism and have implications for the treatment of diabetes
and cancer with complex I inhibitors.aded
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 INTRODUCTION
One-carbon units are an essential requirement for the synthesis of nu-
cleotides and methylation (1). Defects in one-carbon metabolism have
been implicated in several disease states, including neural tube defects
during embryonic development (1) and cancer (2). The nonessential
amino acid serine is the major source of one-carbon units in proliferat-
ing lymphocytes (3, 4) and cancer cells (5, 6). Serine is broken down into
glycine and a one-carbon unit, which can then be incorporated into pu-
rines, thymidylate, andmethionine. From this point of view, serine one-
carbon metabolism has an anabolic function (Fig. 1A).
Serine could also fulfill a catabolic role for energy generation. The
only experimentally verified pathway of serine catabolism for energy
production is the conversion of serine to pyruvate followed by pyruvate
oxidation (Fig. 1B) (7). However, genome-scalemodeling of human cell
metabolism predicts an alternative route for serine catabolism via the fo-
late cycle, contributing to energy generation and coupled to one-carbon
release as formate (serine one-carbon catabolism with formate overflow;
Fig. 1C) (8).
Experimentswith isolatedmitochondria have shown that the carbon
3of serine can be oxidized to formate orCO2 (9).However, it is currently
assumed that the mitochondria-derived formate supports the synthesis
of purines in the cytosol (1), which is an anabolic role. Here, we demon-
strate that most formate is released from mammalian cells rather than
being incorporated into purines.RESULTS
Serine catabolism is induced upon energy stress
First, we focused on the canonical serine catabolism pathway via pyru-
vate (Fig. 1B).We cultured cancer cells and nontransformed lung fibro-
blasts (IMR90) in medium containing [U-13C]serine and determined
the intracellular mass isotopomer distribution (MID) of pyruvate. All
the pyruvate was found with three 12C atoms (M+0 fraction; Fig. 1D
and fig. S1, A and B), indicating no significant conversion of serine to
pyruvate. Therefore, in cancer cells and fibroblasts, there is no signifi-cant activity of the canonical serine catabolism pathway for energy gen-
eration. Next, we evaluated the putative serine one-carbon catabolism
with formate overflow (Fig. 1C). To determine whether and to what ex-
tent cells release formate, we developed a gas chromatography–mass
spectrometry (GC-MS)–based method for the absolute quantification
of formate (fig. S1C) (see Materials and Methods). Using this method,
we determined the exchange rates of formate in addition to those of
serine and glycine, providing a readout for the rate of serine one-carbon
catabolism. We quantified the exchange fluxes of these metabolites in
different cancer cell lines and nontransformed fibroblasts (Fig. 1, E and
F, and fig. S1, D and E). In all cells tested, formate was released at rates
lower but comparable to the rate of serine uptake.Most of the tested cell
lines also showed net glycine release under the conditions tested, albeit
at different ratios relative to serine uptake. To verify that the formate
released is derived from serine, we cultured cells in [U-13C]serine and
determined the formate MID in the cell culture medium. After [U-13C]
serine cultivation, more than half of the medium formate was labeled
(M+1 fraction; Fig. 1G), indicating a significant production of serine-
derived formate. On the basis of the total and theM+1 formate exchange
rate, we estimated that nearly 100% of the formate released by cells is
derived from medium serine (Fig. 1H).
To further demonstrate that serine is themajor source of the formate
released from cells, we titrated the serine concentration in the cell
culture medium. When the medium serine concentration was reduced
from 0.4 to 0.1 mM, there was a significant decrease in the rate of for-
mate release, going down to zero when the culture medium contained
no serine (Fig. 1I). We also noticed that glycine switched from being
released to being taken up when the medium serine concentration
was reduced (Fig. 1I). Therefore, the direction of glycine exchange
is highly dependent on the extracellular concentration of serine, po-
tentially resulting in both glycine uptake and release as previously
reported (6, 10). On the other hand, formate exhibits a net release that
rises with increasing serine concentration in the extracellular medium.
Glycine or formate release could be due to the one-to-one ratio of
glycine and one-carbon unit production from serine but different bio-
synthetic demands of glycine and one-carbon units (11). To reduce the
biosynthetic demands and their potential imbalances, we switched to a
culturemediumwhere glucosewas replaced by galactose. Cells grown in
galactose strongly decrease proliferation (Fig. 1, J and K, and fig. S1, F1 of 10
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 and G), effectively decreasing the biosynthetic demands of glycine and
one-carbon units. Although the exchange rates of essential amino acids
did not significantly change (fig. S1,H to L), the exchange rates of serine,
glycine, and formate significantly increased when cells were switched to
galactose (Fig. 1, L andM, and fig. S1,M toO). The switch from glucose
to galactose is known to cause energy stress and activate adenosine
monophosphate (AMP) kinase (AMPK), a master regulator forMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016switching from anabolism to catabolism (12). We confirmed that
AMPK was activated when cells were switched from glucose to galac-
tose, which is indicated by increased phosphorylation of AMPK and the
AMPK target acetyl–coenzyme A carboxylase (ACC) (fig. S1P). We
note that in one cell line (A549), AMPK phosphorylation did not
change, although phosphorylation of the downstream target ACC
was increased.Fig. 1. Serine catabolism is induced upon energy stress. (A) Current model of serine metabolism to support purine synthesis. dTMP, deoxythymidine monophosphate.
(B) Current model of serine catabolism. (C) Postulated model of serine one-carbon catabolism with formate overflow. OxPhos, oxidative phosphorylation. (D) MIDs of
pyruvate and serine using [U-13C]serine as a tracer in HCT116 colorectal cancer cells and IMR90 human fibroblasts. (E and F) Absolute exchange rates of serine, glycine, and
formate in (E) HCT116 and (F) IMR90 cells. Positive values indicate metabolite release and negative value uptake from cells. Each dot indicates an independent experiment
(performed with three cultures per condition). (G) MID of extracellular formate using [U-13C]serine as a tracer in HCT116, IMR90, A549, and MDA-MB231 cells. (H) Percentage of
formate from medium serine. (I) Serine, glycine, and formate exchange rates at different medium serine concentrations in HCT116 cells (as indicated). S, serine; G,
glycine. (J and K) Proliferation of (J) HCT116 and (K) IMR90 cells upon galactose. The arrow indicates start of galactose treatment. (L and M) Absolute exchange rates of
serine, glycine, and formate in (L) HCT116 and (M) IMR90 cells upon galactose. (N) Percentage of formate from medium serine in HCT116 and IMR90 cells upon glucose
and galactose. (O) MIDs of pyruvate and serine using [U-13C]serine as a tracer in HCT116 and IMR90 cells in galactose medium. Data are presented as means ± SD (n = 3
cultures representative of at least two independent experiments), except for (E) and (F) (see above). *P < 0.05 by Welch’s t test.2 of 10
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 We observed that, under these energy stress conditions, the serine
catabolism to glycine and formate exhibits the highest rate among all
conditions tested. To confirm that the contribution of medium-derived
serine to formate does not decrease under these conditions, we also
tracedmedium [U-13C]serine intomedium formate under the galactose
condition. As observed for the glucose condition, nearly 100% of the
formate released by cells was derived from serine (Fig. 1N). We could
not detect any labeling of pyruvate under the galactose condition, fur-
ther suggesting that serine catabolism takes place via one-carbonmetab-
olism in the cells tested (Fig. 1, D and O).
Serine catabolism is linked to mitochondrial metabolism
Cells grown in galactose have higher oxygen consumption rates
(OCRs) and mitochondrial activity than those grown in glucose
(fig. S2, A and B) (13). This observation prompted us to investigate
a potential link with mitochondrial oxidative phosphorylation. The
one-carbon catabolism of serine proceeds in three metabolic steps
(Fig. 1C), catalyzed by serine hydroxymethyltransferase, 5,10-
methylene-tetrahydrofolate (5,10-CH2-THF) dehydrogenase, and
reverse 10-formyl-tetrahydrofolate (10-CHO-THF) synthetase. On
the basis of current evidence, these reactions take place predominantly
in the mitochondria (1, 14), where they are catalyzed by SHMT2,
MTHFD2 or MTHFD2L, and MTHFD1L, respectively. The de-
hydrogenase activity of MTHFD2 and MTHFD2L can use either
NAD+ (nicotinamide adenine dinucleotide, oxidized) or NADP+ (nic-
otinamide adenine dinucleotidephosphate, oxidized) as a cofactor.
MTHFD2 is the predominant enzyme in proliferating cells (15), and
its in vitro activity is mostly NAD+-dependent (16). Because formate
release increased in the presence of galactose, we hypothesized that the
rate of serine one-carbon catabolism with formate overflow depends
on the availability of NAD+ and, thus, complex I–dependent NADH
(reduced form of NAD+) oxidation.
To test this hypothesis, we used rotenone to inhibit complex I of ox-
idative phosphorylation (Fig. 2A). We observed a drastic reduction of
serine consumption, glycine release, and formate release in all cancer
cell lines tested (Fig. 2B and fig. S2, C to E). We note that, although
the galactose and rotenone treatment conditions are both characterized
by growth inhibition [Figs. 1 (J and K) and 2D, and figs. S1 (F and G)
and S2 (J and K)], formate release exhibits opposite changes. Under the
galactose condition, where mitochondrial NADH oxidation increases,
formate release increases. Upon rotenone treatment, where mitochon-
drial NADHoxidation is inhibited, formate release decreases. Together,
this evidence supports a link between NAD+-dependent MTHFD2 ac-
tivity, NADH oxidation in the mitochondria, and formate production.
These observations are further supported by a recent work by Bao et al.
(17), reporting that respiratory chain dysfunction upon mitochondrial
DNA depletion causes a reduction of formate release from cells.
In the nontransformed IMR90 fibroblasts, serine consumption and
formate release were also reduced upon rotenone treatment, albeit less
markedly (Fig. 2C and fig. S2F). Increasing the rotenone concentra-
tion from the 250 nM that is used in Fig. 2C to 500 and 1000 nM
had no further effect on the rate of formate release by IMR90 cells
(fig. S2F). These data indicate that IMR90 cells have a rotenone-insensitive
component of formate release. We note that rotenone inhibits the
growth (Fig. 2E) and OCR (fig. S2G) of IMR90 cells already at the
250 nM concentration, ruling out the possibility that rotenone is
not having an effect on oxidative phosphorylation in these cells. Because
the cytosolic dehydrogenaseMTHFD1 uses NADP+ and themitochon-
drial dehydrogenase MTHFD2L can use NAD+ or NADP+ as a co-Meiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016factor, we suspected that one or both enzymes could contribute to the
5,10-CH2-THF dehydrogenase activity in IMR90 cells independently of
oxidative phosphorylation. However, quantification of gene expression
by quantitative polymerase chain reaction revealed a similar pattern of
MTHFD2, MTHFD2L, and MTHFD1 expression in HCT116 and
IMR90 cells (fig. S2H), with about the same MTHFD2-to-MTHFD2L
ratio (fig. S2I). Although this evidence cannot rule out differences in
enzymatic activity, it suggests that differences in the dehydrogenase ex-
pression are not responsible for the rotenone-insensitive component of
formate release in IMR90 cells. We can only speculate that, as a
difference to cancer cells (in IMR90 fibroblasts), serine one-carbon ca-
tabolism is partially uncoupled from oxidative phosphorylation.
To further validate whether the serine one-carbon catabolism with
formate overflow takes place in the mitochondria, we targeted
MTHFD1L, the enzyme catalyzing the step of formate release and aden-
osine triphosphate (ATP) production (Figs. 1C and 2A). Knocking
down MTHFD1L by small interfering RNA (siRNA) (Fig. 2F and fig.
S2L), we verified that the formate release from cells is dependent on
mitochondrial MTHFD1L abundance in all cell lines tested, including
the IMR90 fibroblasts (Fig. 2, G and H, and fig. S2, M and N). The for-
mate generated by MTHFD1L can also be recaptured by cytosolic 10-
CHO-THF synthetase (MTHFD1) to satisfy the one-carbon demand
for de novo purine synthesis (1). Therefore, reduction of MTHFD1L
levels could inhibit purine synthesis. However, knockdown of
MTHFD1L did not result in decreased purine levels (Fig. 2, I and J,
and fig. S2, O and P) nor in decreased growth (Fig. 2, K and L, and
fig. S2, Q andR). The residual activity of the remainingMTHFD1L pro-
tein or the cytosolic enzyme (MTHFD1) appears to be sufficient to sat-
isfy the one-carbon unit demand for purine synthesis and thus to
sustain growth rates similar to nonsilenced cells. On the basis of recent
data from another group, the cytosolic pathway can compensate for the
requirement of one-carbon units in cells, where a mitochondrial
pathway enzyme (including SHMT2, MTHFD2, and MTHFD1L) has
been knocked out (18). Together, these results indicate that the mito-
chondrial serine catabolism to glycine and formate is dispensable for
purine synthesis and growth.
Another potential function of the serine catabolism to glycine and
formate could be energy generation. For every formate released from
cells, one adenosine diphosphate (ADP) molecule is phosphorylated
to form ATP via reverse mitochondrial 10-CHO-THF synthetase
(Fig. 1C). The coupling of the mitochondrial NAD+-dependent 5,10-
CH2-THF dehydrogenase to mitochondrial oxidative phosphorylation
can contribute with an additional 2.5 molecules of ATP per formate
molecule released, giving an overall yield of 3.5 ATP per formate. As
reported above, MTHFD1L knockdown did not result in decreased pu-
rine levels, including ATP (Fig. 2, I and J, and fig. S2, O and P). There-
fore, we hypothesized that another pathway for energy generation
should compensate for the reduced energy yield by the serine catabo-
lism to formate and glycine. Because glycolysis is a potential candidate
to fulfill this role, we quantified the rate of lactate release. MTHFD1L
knockdown resulted in increased lactate release in HCT116 cells (Fig. 2,
M and N). In these cells, MTHFD1L knockdown decreases formate ef-
flux by ~11 fmol cell−1 hour−1 (Fig. 2G). The expected energy deficit is
given by the drop in formate release times 3.5 ATP per formate, that is,
about 38.5 fmol cell−1 hour−1 for HCT116 cells upon MTHFD1L
knockdown. We measured an increase in lactate release of ~100 fmol
cell−1 hour−1, relative to control (Fig. 2, M and N). Because glycolysis
has a yield of 1 ATP per lactate, the increase in glycolysis is overcom-
pensating for the reduction in ATP generation by the serine catabolism3 of 10
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 to formate. In IMR90 cells, formate release is, up to a great extent,
rotenone-independent and thus uncoupled from NADH oxidation.
In this case, we expect a yield of 1 ATP per formate. In IMR90 cells,
formate release goes down by 6 fmol cell−1 hour−1 when MTHFD1L
is silenced, and lactate release goes up by 18 fmol cell−1 hour−1 (albeit
within the experimental error and not significant). We obtained the
same results at physiological glucose conditions (5.5 mM): a signif-
icant increase in lactate release in HCT116 cells and no significant
increase in IMR90 cells (Fig. 2N). Work from another group has
shown that knockdown of MTHFD2 also results in increased lactate
release in theMCF7 breast cancer cells (19). Together, the lack of any
phenotype regarding purine levels and growth in MTHFD1LMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016knockdown cells, but an increase in glycolysis, suggests a catabolic
rather than an anabolic role of the serine one-carbon catabolism to
glycine and formate.
Formate efflux exceeds anabolic one-carbon demands
To further demonstrate that formate release is the dominant fate of
one-carbon production, we quantified the rate of purine synthesis
and compared the result with the rate of formate release (Fig. 3). In
the HCT116 colon cancer cell line, we determined a purine synthe-
sis flux of 1.4 fmol cell−1 hour−1 (Fig. 3B), 10-fold lower than the
measured average formate release flux (16.18 fmol cell−1 hour−1;
Fig. 1E). Similarly, the IMR90 nontransformed lung fibroblastsFig. 2. Serine catabolism is linked to mitochondria. (A) Model illustrating mitochondrial one-carbon metabolism and its potential dependency on complex I. (B and
C) Absolute exchange rates of serine, glycine, and formate in (B) HCT116 and (C) IMR90 cells upon rotenone. (D and E) Proliferation of (D) HCT116 and (E) IMR90 cells
upon rotenone. (F) Western blot confirming knockdown of MTHFD1L in HCT116 and IMR90 cells. (G and H) Absolute exchange rates of serine, glycine, and formate in
(G) HCT116 and (H) IMR90 cells upon MTHFD1L knockdown. (I and J) Absolute intracellular purine levels in (I) HCT116 and (J) IMR90 cells upon MTHFD1L knockdown.
GMP, guanosine monophosphate; GTP, guanosine triphosphate. (K and L) Proliferation of (K) HCT116 and (L) IMR90 cells upon MTHFD1L knockdown. (M and N) Lactate
release rates of HCT116 and IMR90 cells upon MTHFD1L knockdown under (M) high-glucose (17 mM) and (N) low-glucose (5.5 mM) conditions. Data are presented as
means ± SD (n = 3 cultures representative of at least two independent experiments), except for (F) (one culture). *P < 0.05 by Welch’s t test.4 of 10
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 produce purines at a rate between 0.3 and 0.4 fmol cell−1 hour−1
(Fig. 3C), 25-fold lower than the rate of formate release (10.31 fmol
cell−1 hour−1; Fig. 1F). The purine synthesis rates were also 10-fold
lower in the two other cell lines tested (fig. S3, G and H). In addition,
we examined the effect of rotenone and MTHFD1L knockdown on
serine one-carbon metabolism fluxes and revealed that only rotenone
decreased the purine synthesis flux, whereas MTHFD1L knockdown
did not result in such a strong decrease in this biosynthetic flux (Fig. 3,
B and C, and fig. S3, G and H). These results are in line with the ob-
served effect on growth repression upon rotenone, but not MTHFD1L
knockdown [Fig. 2D (E, K, and L) and fig. S2 (J, K, Q, and R)]. Be-
cause rotenone simultaneously reduces purine synthesis flux and
growth, the measured purine levels remained constant in the case of
HCT116 and were only moderately reduced in the case of IMR90 (fig.
S3, E and F).Meiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016To cover all major sources/sinks of serine and glycine, we also
determined the rate of serine synthesis from glucose, serine, and
glycine flux to proteins and from glycine to glutathione (GSH)
(fig. S3, A to D) to ultimately present an overall picture of major
cellular serine/glycine/one-carbon metabolism fluxes (Fig. 3A). We
note that there is also a demand of one-carbon units for thymidy-
late synthesis. However, this demand is significantly lower than
that for purine synthesis, and its value is within the error of our
measurements. The serine synthesis rates were estimated from
the metabolic flux analysis (MFA) model for serine (20, 21). The
MFA model takes into account the import of serine, the synthesis
of serine from glucose, and the reverse flux of serine hydroxy-
methyltransferase. In the context of a [U-13C]serine tracer, the lat-
ter is reflected in the formation of M+1 serine from the M+1 fraction
of 5,10-CH2-THF and M
+0 glycine. Under all conditions tested,Fig. 3. Formate efflux exceeds anabolic one-carbon demands. (A) Model summarizing major cellular serine–derived fluxes in mammalian cells. (B and C) Absolute
purine synthesis flux in (B) HCT116 and (C) IMR90 cells. (D and E) Pie charts representing fluxes of serine, glycine, and one-carbon moieties in (D) HCT116 and (E) IMR90
cells under normal conditions. The numbers underneath the pie chart represent the summed contribution of all sinks reported in the pie chart above (per cell per hour). We
note that these pie charts just reflect the average measurements [see (B) and (C) and fig. S3 (A to D) for the measurement errors of each specific contribution]. SHMT, serine
hydroxymethyltransferase. Data are presented as means ± SD (n = 3 cultures representative of at least two independent experiments). *P < 0.05 by Welch’s t test.5 of 10
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 serine synthesis from glucose represents less than 10% of total ser-
ine production (from extracellular glucose and serine). Rotenone
treatment decreased the rate of serine synthesis from glucose (fig.
S3A). This observation is consistent with the requirement of an
NAD+-dependent dehydrogenase step (catalyzed by PHGDH) in
the serine biosynthesis and the inhibition of NADH oxidation by
rotenone treatment.
We summarized the MFA in a flux pie chart that shows the ex-
cessive serine-derived formate efflux, which is about 10-fold above
the purine synthesis flux (Fig. 3, D and E). For glycine, we observe
two different scenarios. In the A549 lung and MDA-MB231 breast
cancer cell lines grown in glucose, the production of glycine from
serine matches approximately its demand for biosynthesis, and
there is a small rate of glycine release into the extracellular medium
(fig. S1, D and E). In these cell lines, excess production of one-carbon
units and thus formate release can be explained by the cellular de-
mand of glycine. There is an imbalance between equal rates of glycine
and one-carbon unit production from serine and a higher biosynthetic
demand of glycine than one-carbon units. This scenario has been hy-
pothesized previously (11), predicting that the excess one-carbon units
would be released as CO2 by 10-CHO-THF dehydrogenase. However,
as shown here, formate is a major route of one-carbon unit release in
A549 and MDA-MB231 cells. In the remaining cell lines, there is an
excess production of glycine from serine that is released from cells. In
this context, the flux of serine catabolism to glycine and one-carbon
unit cannot be explained by biosynthetic imbalances. Our calculations
also indicate 25 to 50% of unaccounted one-carbon unit consumption,
not explained by the demands for purine synthesis and formate efflux
(Fig. 3, D and E). Most likely, this unknown sink represents the overall
activity of cytosolic and mitochondrial 10-CHO-THF dehydrogenases.
Serum formate depends on serine catabolism in vivo
Investigations of whole-body formate metabolism indicate that there is
a significant amount of formate release into the blood (22). However,
the origin of the formate remains largely unconfirmed. The in vitro
evidence reported above suggests serine as a potential source. To de-
termine whether serine one-carbon catabolism with formate overflow
takes place in vivo, we performed a serine-tracing experiment in wild-
type (WT) C57BL/6 mice. This approach was combined with phen-
formin to test the dependency of serine catabolism to formate on
complex I activity. The antidiabetic drugs phenformin and metformin
are biguanides with reported inhibitory activity against complex I (23).
To exclude carbon contribution from glycine cleavage, which is active
in certain organs such as liver and kidneys, we used a [3-13C1]serine
tracer. Serine labeled with 13C at carbon 3 transfers 13C to 5,10-CH2-
THF only via the serine hydroxymethyltransferase activity, whereas
glycine cleavage would donate carbon 2 (12C) 12C of serine. Mice were
fasted overnight before the start of the experiment. We administered a
bolus of [3-13C1]serine via intraperitoneal injection (±phenformin) and
collected blood samples at 15, 30, and 60 min after injection (Fig. 4A),
with parallel sampling of four mice per time point. We also conducted
an independent pilot experiment with three mice per time point,
showing the same overall trend.
The plasma levels of serine, glycine, and formate were just slightly
above the values in mice injected with a phosphate-buffered saline
(PBS) bolus (fig. S4, A to C). We confirmed the appearance of [3-13C1]
serine in the plasma following its intraperitoneal injection (Fig. 4B).
[3-13C1]serine levels were highest at 15 min after injection and grad-
ually decreased over time. However, clearance rates were different inMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016the control and the phenformin group, resulting in significantly higher
M+1 serine levels in the phenformin group at the 30- and 60-min time
points (Fig. 4B).We observed the appearance of [13C]formate in plas-
ma (Fig. 4C), supporting the generation of formate from serine in vivo.
Fifteen minutes after injection, formate M+1 concentration was lower
in the phenformin group, suggesting a decrease in formate generation
fromserine (Fig. 4C). In contrast, at the 30- and 60-min time points,M+1
formate concentrations were higher in the phenformin group, which
could be explained by a concomitant decrease in formate turnover
(Fig. 4C). Given the labeling pattern of serine and the observed concen-
trations of [13C]formate in WT mice, we estimated a rate of serine-
derived formate production of 5.1 ± 0.3mmol kg−1 hour−1, representing
about 50% of total formate production (42% in the independent pilot
experiment). The remaining 50% could originate from glycine cleavage,
cholesterol synthesis, and demethylation. Phenformin treatment resulted
in a 1.3-fold [95% confidence interval (CI), 1.1 to 1.5] reduction of the
estimated rate of formate generation from serine (Fig. 4D). This observa-
tion confirmed the trend observed in the independent pilot experiment,
where phenformin treatment resulted in a 1.7-fold (95% CI, 0.7 to 3.3)
reduction of the estimated rate of formate generation from serine.
To further demonstrate that serine is a significant source of for-
mate in vivo, we investigated the impact of a serine/glycine-deficient
diet (−SG diet) on plasma formate levels. We set C57BL/6 WT mice
on a serine/glycine-deficient diet for 3 weeks to monitor serine and
formate levels in the blood (Fig. 4E). After 3 weeks of starvation, we
observed a significant reduction of serum formate concentration (Fig.
4F). We also observed a linear correlation between serine and formate
levels, independently of the diet, with the −SG diet mice shifted to
lower serine/formate levels (Fig. 4G). In an alternative attempt, we
took advantage of a parallel experiment testing the impact of serine
deprivation on cancer-related survival in the APCmin mouse model
for colorectal cancer. APCmin mice die of tumor burden at 130 days
of age on average. Eighty-day-old APCmin mice were set on a −SG
diet until clinical end point (tumor-related survival, approximately
50 days). At the time of death, blood samples were collected. Using
these samples, we retrospectively analyzed serum formate levels.
Serine-starved APCmin mice had a 32% lower plasma formate con-
centration on average compared to the control group, fed a diet
containing serine and glycine (Fig. 4F). As in WT mice, formate
levels also linearly correlated with plasma serine levels (Fig. 4H).
These data indicate that serine availability determines formate
levels in blood, providing further support for serine as a significant
source of formate in vivo.DISCUSSION
Here, we demonstrate that cells run serine one-carbon catabolism in
excess of the biosynthetic demand of one-carbon units. Most of the
excess one-carbon units are released as formate under the conditions
tested. For every formate molecule released from cells, one ADP mol-
ecule is phosphorylated to form ATP via reverse mitochondrial 10-
CHO-THF synthetase (Fig. 1C). The coupling of the mitochondrial
NAD+-dependent 5,10-CH2-THF dehydrogenase to mitochondrial
oxidative phosphorylation can contribute with an additional 2.5 mole-
cules of ATP per formate molecule released. The only cell-autonomous
phenotype we have observed in MTHFD1L knockdown cells is an in-
crease in glycolysis, a canonical pathway for energy generation, in the
HCT116 colorectal cancer cells but not in the IMR90 nontransformed
lung fibroblasts. Although this evidence is not conclusive, it supports6 of 10
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 the idea that serine one-carbon catabolism with formate overflow can
contribute to energy generation. Further work is required to investigate
whether this contribution is enhanced in certain cancers relative to
normal tissues.
Some cancer cells exhibit a high rate of formate release but almost
no glycine release when growing in standard culture medium. There-
fore, we cannot exclude the possibility that excess one-carbon unit
production is a side effect of glycine generation from serine and a
higher metabolic demand of glycine than one-carbon units (11). How-
ever, if such hypothesis is correct, then we would need to resort to
additional hypotheses to explain why mammalian cells evolved to gen-
erate glycine from serine when glycine is available in the extracellular
medium and why the excess one-carbon units are mostly released as
formate instead of as less toxic CO2.
The demonstration of serine catabolism with formate overflow has
several implications to our understanding of mammalian metabolism
in normal physiology and disease states. Of greatest importance is the
use of metformin, a less potent complex I inhibitor than phenformin,
for the treatment of type 2 diabetes. Although metformin has different
organ-specific pharmacokinetics than phenformin, both drugs target
complex I. Our data suggest a reduction in plasma formate levels as
a consequence of treatment with complex I inhibitors. It will be
interesting to investigate whether formate levels are reduced in type
2 diabetes patients under long-term metformin treatment and whether
lower formate levels are simply a consequence of the treatment or
whether they might even have a direct impact on the phenotype.
Metformin is also currently being investigated for the treatment of
cancer. A study in mice has shown that metformin treatment syner-
gizes with serine deprivation in the growth inhibition of mouse xeno-
graft tumors (24). The evidence reported here indicates that bothMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016treatment strategies inhibit the serine one-carbon catabolism to for-
mate, potentially contributing to the observed synergy.
The phenomenon uncovered here, serine one-carbon catabolism
with formate overflow, resembles the well-known phenotype of glu-
cose catabolism with lactate overflow [the Warburg effect (25)]. Both
phenotypes are characterized by the apparent “waste” of carbon atoms
and energy production. They are different with respect to localization.
The Warburg effect contributes to the cytosolic, and the serine one-
carbon catabolism contributes to the mitochondrial energy generation.
They also differ in the magnitude of the pathway rate, with glucose
catabolism being significantly higher than serine catabolism. However,
this rate difference is not unexpected, considering that mitochondria
represent a low percentage of the biomass content of normal prolifer-
ating cells and cancer cells [table S1 in Vazquez et al. (26)]. Finally,
similar to the resynthesis of glucose from lactate in the liver via the
Cori cycle, serine could be resynthesized in the liver, contributing to
the organism balance of energy and one-carbon units.MATERIALS AND METHODS
Cell culture
All cell lines were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) 5030 (Thermo Fisher Scientific) with addition of 2 mM glu-
tamine, 17 mM glucose, and 10% fetal bovine serum (FBS) at 37°C
and 5% CO2. IMR90 cells were cultured identically with the exception
of 20% FBS. In the case of galactose experiments, glucose was replaced
by 17 mM galactose at the start of the experiment. HCT116 and A549
cells were obtained from the group of K. Vousden (Cancer Research
U.K. Beatson Institute), and MDA-MB231 and K562 cells were ob-
tained from the group of E. Gottlieb (Cancer Research U.K. BeatsonFig. 4. Serum formate depends on serine catabolism in vivo. (A) Model illustrating the setup to trace serine-derived formate formation in vivo. (B) Abundance of
serine M+1 isotopologues in plasma, 15, 30, and 60 min after injection with or without phenformin. (C) Concentration of formate M+1 isotopologue in plasma, 15, 30,
and 60 min after injection with or without phenformin. (D) Estimated serine-derived formate synthesis rate in phenformin-treated or phenformin-untreated mice (see
text for reported CIs). (E) Model illustrating the experimental setup for serine/glycine (−SG) starvation, to measure its effect on serum formate level. (F) Formate
concentration in the serum of serine- and glycine-starved mice [3 weeks starvation in WT mice (n ≥ 5) and in APCmin mice at clinical end point (n ≥ 12)]. We note
the exclusion of one outlier in the 3-week setup (see fig. S4, D and E). (G and H) Correlation between serine and formate levels in (G) WT and in (E) APCmin mice in
respect to serine/glycine starvation. Data are presented as means ± SD [(B to D) n = 4 mice per condition and time point]. *P < 0.05 by Welch’s t test.7 of 10
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 Institute). IMR90 fibroblasts were obtained from the group of P.
Adams (University of Glasgow). All cell lines were checked for
mycoplasma contaminations. All experiments were performed in trip-
licate wells per condition, unless otherwise stated, and were repeated
at least twice to monitor biological variance in addition to phenotype
verification across different genetic backgrounds (different cell lines).
Rotenone (Sigma-Aldrich) was used at a final concentration of 250 nM.
For low-glucose conditions, cells were cultured in minimum essen-
tial medium (MEM) (Thermo Fisher Scientific, 11090-081; 5.5 mM
glucose) with the addition of 2 mM glutamine, 400 mM serine, and
400 mM glycine.
siRNA-mediated gene silencing
To silence MTHFD1L, 10 pmol of SMARTpool siRNA (GE Dharma-
con, L-009949-01-0005), 2.5 ml of Lipofectamine 2000 (Invitrogen),
and 200 ml of Opti-MEM (Thermo Fisher Scientific) were mixed
and incubated at room temperature for 20 min. As a control, a non-
targeting siRNA control was used instead (GE Dharmacon, D-
001810-10-05). During 20 min of incubation, cells were trypsinized,
counted, and diluted to the desired concentration (150 to 250 K cells
per well). After 20 min of siRNA incubation, 200 ml of the siRNA-
Lipofectamine mix was aliquoted in 1 well of a 12-well plate. Next,
800 ml of cell suspension was added to each well. The next day, me-
dium was replaced by complete medium. Knockdown was verified
48 to 72 hours after transfection by Western blot. In the case of
growth assays, time point 0 corresponds to the time of medium
replacement after transfection. Cells were counted with a CASY cell
counter (OLS).
Stable isotope labeling
Stable isotope experiments were performed in MEM (Thermo Fisher
Scientific, 11090-081), with the addition of 400 mM glycine, 2 mM
glutamine, 17 mM glucose, 400 mM serine, and 10% FBS. To allow
for adaptation to the different cell culture media, we cultured cells
for at least one passage in complete MEM before the start of the ex-
periment. At the start of the experiment, 150,000 cells were seeded in
12-well plates. In the case ofMTHFD1L knockdown, transfection was
performed as described in the previous section. Extra triplicate wells
were seeded accordingly to count cells at the start and end of the ex-
periment. The next day, medium was replaced, and cells were cultured
for an additional 24 hours. At the start of the experiment, three wells
per condition were counted to assess cell number. For tracing, cells were
washed once with PBS, and medium was replaced with 400 mM
[U-13C]serine-containing medium. Cells were incubated for the indi-
cated times (8 hours for HCT116 and A549 and 16 hours for MDA-
MD231 and IMR90). At the extraction time point, triplicate wells were
counted to assess cell number at the end of the experiment, and one
set of triplicate wells was used for metabolite extraction. Medium of
the extracted cells was collected and analyzed for exchange rates. To
determine consumption rates, the same medium had been incubated
in empty wells for the same time in the incubator.
Metabolite extraction
For the extraction of intracellular metabolites and the quantification of
exchange rates, medium was collected and, for the extraction of intra-
cellular metabolites, cells were washed with PBS, and 400 ml of ice-cold
extraction fluid [acetonitrile/H2OMQ/methanol (ratio, 3:2:5); liquid
chromatography–MS (LC-MS) grade solvents)] was added immedi-
ately to each well. Plates were incubated at 4°C for 5 min on a rockingMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016shaker. After 5 min, supernatant was collected in 1.5-ml Eppendorf
tubes, vortexed, and subsequently centrifuged for 5 min at 13,000g
at 4°C. Two hundred microliters of supernatant was transferred into
LC-MS glass vials with inserts and stored at −80°C until measurement.
Collected medium was centrifuged at 300g for 5 min at 4°C to pel-
let cellular debris. Medium supernatant was collected in Eppendorf
tubes and stored at −80°C until extraction of metabolites. For the ex-
traction of metabolites, 10 ml of medium was diluted in 990 ml of ice-
cold extraction fluid, vortexed, and centrifuged at 13,000g for 5 min at
4°C. For the specific quantification of lactate, samples were extracted
with extraction solvent containing 100 mM [U-13C]lactate as internal
standard. Supernatant was transferred into LC-MS glass vials and
stored at −80°C until measurement. For the measurement of serum-
or plasma-derived metabolites, 5 ml of sample was mixed with 250 ml
of extraction fluid and vortexed for 10 min at 4°C. Further procedures
were equivalent to medium-derived metabolite extraction.
Formate extraction, derivatization, and quantification
Forty microliters of sample was added to a 1.5-ml microfuge tube,
followed by 20 ml of 1 mM internal standard sodium 13C,2H-formate
(M+2) (Sigma-Aldrich, CAS 1215684-17-5), 10 ml of benzyl alcohol
(Sigma-Aldrich, CAS 100-51-6), 10 ml of 1 M sodium hydroxide,
and 50 ml of pyridine. The tube was then placed on ice for 5 min.
Derivatization was started by adding 20 ml of methyl chloroformate
with vigorous vortexing for 20 s. Note that derivatization should be
performed in a fume hood as gases were produced during the reaction.
After vortexing, 200 ml of water and 100 ml of methyl tertiary butyl
ether were added, and the sample was vortexed for another 20 s
and centrifuged at 10,000g for 5 min. Forty-five microliters of the re-
sulting upper layer containing formate derivative (benzyl formate) was
transferred to a GC glass vial and stored at −80°C until analysis. For
the quantification of formate in mouse serum samples, we used the
same procedure with the exception of the concentration of the internal
standard at 50 mM.
Determination of intracellular purine and GSH levels
For the determination of absolute intracellular purine and GSH levels,
the standard addition method was used. Briefly, respective standards
were prepared in extraction solvent and spiked in different concentra-
tions into extracts of WT cells. Instead of 400 ml of extraction volume,
cells were extracted with 380 ml of extraction volume and 20 ml of a
standard mix containing a defined concentration of ATP, and guano-
sine triphosphate and GSH were added. The following standards were
used: 0, 40, 80, and 200 mM.
Protein quantification and determination of serine and
glycine flux into total protein
For quantification of intracellular protein content, a Bradford assay
(Sigma-Aldrich) was used according to the manufacturer’s instruc-
tions. Signal was recorded in 96-well plates at 595 nm. Protein content
was determined in microgram per cell.
Oxygen consumption rates
To measure OCRs, we used the Extracellular Flux Analyzer (Sea-
horse Biosciences). Briefly, 30,000 cells per well of a 96-well plate
(Seahorse Bioscience) were seeded the day before the experiment.
The culture medium was DMEM 5030 (as described in the “Cell
Culture” section). Immediately before the start of the experiment,
8 wells from the same 96-well plate were trypsinized and counted8 of 10
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 to assess cell number per well. OCR was determined according to
the manufacturer’s conditions.
Western blot
Proteins were extracted using radioimmunoprecipitation assay
buffer (Thermo Fisher Scientific) with the addition of Halt Protease
and Phosphatase Inhibitor Cocktail (100×) (Thermo Fisher Scientific)
at a 1× final concentration. Approximately 100 ml of extraction buffer
was used per 100,000 cells. Cells were cultured in 12-well plates. Pro-
teins were separated in 10% precast SDS gels (Bio-Rad) at 200 V for
40 min. Proteins were transferred to nitrocellulose membrane
(Amersham) and blocked with 7% milk powder in tris-buffered
saline–Tween 20 (TBS-T) for at least 1 hour (at room temperature)
or overnight (at 4°C) on a rocking shaker. Blots were washed with
TBS-T to remove residual milk powder and were incubated with
primary antibody (1:1000 in TBS-T) for 1 hour at room temperature
on a rocking shaker: anti–b-actin (Cell Signaling, 8457P), anti-
MTHFD1L (Proteintech, 16113-1-AP), anti-AMPKa [AMPKa,
D5A2; monoclonal antibody (mAb) #5831, Cell Signaling], anti–
phospho-AMPKa (Thr172, 40H9; mAb #2535, Cell Signaling), ACC
(C83B10; mAb #3676), and anti–phospho-ACC (Ser79, D7D11;
mAb #11818). After incubation, blots were washed three times for
10 min with TBS-T and incubated with the secondary antibody [IR-
Dye 800CW donkey anti-rabbit immunoglobulin G (H + L); 1:5000
(LI-COR, 926-32213)] for 1 hour at room temperature on a rocking
shaker. After incubation, blots were washed three times for 10 min
with TBS-T. Fluorescence signals were recorded using the Odyssey an-
alyzer (LI-COR) with respective software package (Image Studio Lite).
LI-COR software was also used for image processing before exporting
as TIFF files. Final image assembly was carried out using Inkscape
software package (https://inkscape.org). Images were exported as .eps
files and imported into Prism 6 for final figure assembly.
LC-MS measurements
The LC-MS method has been previously described in the studies
by Tedeschi et al. (21, 27) and Patella et al. (21, 27). A Q Exactive
Orbitrap mass spectrometer (Thermo Fisher Scientific) was used,
together with a Thermo UltiMate 3000 high-performance liquid
chromatography (HPLC) system. The HPLC setup consisted of a
ZIC-pHILIC column (SeQuant, 150 mm × 2.1 mm; Merck KGaA,
5 mm), with a ZIC-pHILIC guard column (SeQuant, 20 mm × 2.1 mm)
and an initial mobile phase of 20% of 20 mM ammonium carbonate
(pH 9.4) and 80% acetonitrile. Cell and medium extracts (5 ml) were
injected, and metabolites were separated over a 15-min mobile phase
gradient, decreasing the acetonitrile content to 20%, at a flow rate of
200 ml/min and a column temperature of 45°C. The total analysis time
was 23 min [adapted from the study by Tedeschi et al. (21)]. All me-
tabolites were detected across a mass range of 75 to 1000 mass/charge
ratio (m/z) using the Exactive mass spectrometer at a resolution of
25,000 (at 200 m/z), with electrospray ionization and polarity switching
to enable both positive and negative ions to be determined in the same
run. Lock masses were used, and the mass accuracy obtained for all
metabolites was below 5 parts per million. Data were acquired using
Thermo Xcalibur software.
The peak areas of different metabolites were determined using
Thermo TraceFinder software, where metabolites were identified
by the exact mass of the singly charged ion and by known retention
time on the HPLC column. Commercial standards of all metabo-
lites detected had been previously analyzed on this LC-MS systemMeiser et al. Sci. Adv. 2016;2 : e1601273 28 October 2016with the ZIC-pHILIC column. The 13C-labeling patterns were
determined by measuring the peak areas for the accurate mass of
each isotopologue of a given metabolite [adapted from the study by
Patella et al. (27)]. Integrated peak areas had been extracted and
used for further quantifications. To determine the relative intra-
cellular metabolite abundance, we normalized integrated peak areas
to the cell count at the end of the experiment.
GC-MS measurements
Derivatized formate samples were analyzed with an Agilent 7890B
GC system coupled to a 7000 triple quadrupole MS system. The
column was a Phenomenex ZB-1701 column (30 m × 0.25 mm ×
0.25 mm). Samples (2 ml) were injected into the GC-MS using split
mode [0.5 bars; split flow (25 ml/min)]. Gas flow through the column
was held constant at 1.0 ml of He per minute. The temperature of the
inlet was 280°C, the interface temperature was 230°C, and the quad-
rupole temperature was 200°C. Reduced electron energy (60 eV) was
used for analyte ionization. The column was equilibrated for 3 min
before each analysis. The mass spectrometer was operated in selected
ion monitoring (SIM) mode between 3.0 and 4.3 min with SIM masses
of 136, 137, and 138 for M0, M+1, and M+2 (internal standard) formate,
respectively. The utilized oven program is described in table S1.
The total run time of a sample was 5.97 min. Natural isotope abun-
dance was taken into account and subtracted, as described in the Sup-
plementary Materials.
Recorded data were processed using the MassHunter Software
(Agilent). Integrated peak areas were extracted and used for further
quantifications using in-house software packages.
In vivo work
All animal work was carried out under PPL 70/8468 in line with the
Animals (Scientific Procedures) Act 1986 and the European Union
Directive 2010 and was sanctioned by the local ethical review pro-
cess (University of Glasgow). Male C57BL/6J mice (stock number,
000664; at least 20 g in weight) were purchased from Charles River.
Thirty milligrams of [3-13C1]serine was dissolved in 6 ml of PBS.
The 6 ml was split into 2 ml × 3 ml, and 30 mg of phenformin was
added to one tube. Both tubes were sterile-filtered and used for in-
traperitoneal injection. As a control, only one group was injected
with PBS, and 200 ml of solution was injected per mouse. Mice were
randomly assigned to seven groups (four mice per group: three groups
for [3-13C1]serine, three groups for [3-
13C1]serine + phenformin, and
one group for PBS) and were injected intraperitoneally. Mice were sac-
rificed 15, 30, or 60 min after injection (15 min only for PBS group) by
Schedule 1 method. Whole blood was collected and centrifuged at
13,000 rpm for 5 min, and sera were transferred to clean tubes and
snap-frozen on dry ice.
For serine starvation, APCmin (28) or C57BL/6 mice were housed
under same conditions. APCmin mice were housed until day 80. At
that time point, the cohort was split into a control group (full diet)
and a serine/glycine-deficient diet (−SG) group. The control group
consisted of 14 mice, and the −SG group consisted of 12 mice. Mice
were sacrificed individually, depending on the progression of tumor
burden. WT mice were split into two groups, consisting of six mice
each, and were kept on specific diets for 3 weeks. Whole blood was
collected and processed to serum, as described in the previous section.
Formate analysis in sera from the serine starvation experiment was
performed in a blinded manner. Mouse IDs were assigned to the
results, retrospectively.9 of 10
SC I ENCE ADVANCES | R E S EARCH ART I C L ESUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/2/10/e1601273/DC1
Supplementary Text
fig. S1 Serine catabolism is induced upon energy stress.
fig. S2. Serine catabolism is linked to mitochondria.
fig. S3. Formate efflux exceeds anabolic one-carbon demands.
fig. S4. Serum formate depends on serine catabolism in vivo.
table. S1. GC temperature program for formate analysis.
References (29–31) o
n
 April 13, 2017
http://advances.sciencem
ag.org/
D
ow
nloaded from
 REFERENCES AND NOTES
1. A. S. Tibbetts, D. R. Appling, Compartmentalization of mammalian folate-mediated one-
carbon metabolism. Annu. Rev. Nutr. 30, 57–81 (2010).
2. J. W. Locasale, Serine, glycine and one-carbon units: Cancer metabolism in full circle.
Nat. Rev. Cancer 13, 572–583 (2013).
3. R. W. Allen, M. Moskowitz, Arrest of cell growth in G1 phase of cell cycle by serine
deprivation. Exp. Cell Res. 116, 127–137 (1978).
4. P. B. Rowe, D. Sauer, D. Fahey, G. Craig, E. Mccairns, One-carbon metabolism in
lectin-activated human-lymphocytes. Arch. Biochem. Biophys. 236, 277–288 (1985).
5. O. D. K. Maddocks, C. R. Berkers, S. M. Mason, L. Zheng, K. Blyth, E. Gottlieb, K. H. Vousden,
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer
cells. Nature 493, 542−546 (2013).
6. C. F. Labuschagne, N. J. F. van den Broek, G. M. Mackay, K. H. Vousden, O. D. K. Maddocks,
Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer
cells. Cell Rep. 7, 1248–1258 (2014).
7. D. Voet, J. G. Voet, Biochemistry (John Wiley & Sons Inc., ed. 4, 2011).
8. A. Vazquez, E. K. Markert, Z. N. Oltvai, Serine biosynthesis with one carbon catabolism and
the glycine cleavage system represents a novel pathway for ATP generation. PLOS ONE 6,
e25881 (2011).
9. L. F. Garcia-Martinez, D. R. Appling, Characterization of the folate-dependent
mitochondrial oxidation of carbon 3 of serine. Biochemistry 32, 4671–4676
(1993).
10. M. Jain, R. Nilsson, S. Sharma, N. Madhusudhan, T. Kitami, A. L. Souza, R. Kafri,
M. W. Kirschner, C. B. Clish, V. K. Mootha, Metabolite profiling identifies a key role for
glycine in rapid cancer cell proliferation. Science 336, 1040–1044 (2012).
11. M. E. Brosnan, L. MacMillan, J. R. Stevens, J. T. Brosnan, Division of labour: How does folate
metabolism partition between one-carbon metabolism and amino acid oxidation?
Biochem. J. 472, 135–146 (2015).
12. D. G. Hardie, F. A. Ross, S. A. Hawley, AMPK: A nutrient and energy sensor that maintains
energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251–262 (2012).
13. B. H. Robinson, R. Petrova-Benedict, J. R. Buncic, D. C. Wallace, Nonviability of cells with
oxidative defects in galactose medium: A screening test for affected patient fibroblasts.
Biochem. Med. Metab. Biol. 48, 122–126 (1992).
14. C. A. Lewis, S. J. Parker, B. P. Fiske, D. McCloskey, D. Y. Gui, C. R. Green, N. I. Vokes,
A. M. Feist, M. G. Vander Heiden, C. M. Metallo, Tracing compartmentalized NADPH
metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell 55, 253–263
(2014).
15. J. Meiser, A. Vazquez, Give it or take it: The flux of one-carbon in cancer cells. Febs J.,
10.1111/febs.13731 (2016).
16. G. K. Smith, S. D. Banks, T. J. Monaco, R. Rigual, D. S. Duch, R. J. Mullin, B. E. Huber,
Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal
tissue, neoplastic cells, and oncogene-transformed cells. Arch. Biochem. Biophys. 283,
367–371 (1990).
17. X. R. Bao, S. E. Ong, O. Goldberger, J. Peng, R. Sharma, D. A. Thompson, S. B. Vafai,
A. G. Cox, E. Marutani, F. Ichinose, W. Goessling, A. Regev, S. A. Carr, C. B. Clish,
V. K. Mootha, Mitochondrial dysfunction remodels one-carbon metabolism in human
cells. eLife 5, pii: e10575 (2016).
18. G. S. Ducker, L. Chen, R. J. Morscher, J. M. Ghergurovich, M. Esposito, X. Teng, Y. Kang,
J. D. Rabinowitz, Reversal of cytosolic one-carbon flux compensates for loss of the
mitochondrial folate pathway. Cell Metab. 23, 1140–1153 (2016).Meiser et al. Sci. Adv. 2016;2 : e1601273 28 October 201619. C. Koufaris, S. Gallage, T. Yang, C. H. Lau, G. N. Valbuena, H. C. Keun, Suppression of
MTHFD2 in MCF-7 breast cancer cells increases glycolysis, dependency on exogenous
glycine, and sensitivity to folate depletion. J. Proteome Res. 15, 2618–2625 (2016).
20. J. Fan, J. J. Kamphorst, R. Mathew, M. K. Chung, E. White, T. Shlomi, J. D. Rabinowitz,
Glutamine-driven oxidative phosphorylation is a major ATP source in transformed
mammalian cells in both normoxia and hypoxia. Mol. Syst. Biol. 9, 712 (2013).
21. P. M. Tedeschi, N. Johnson-Farley, H. Lin, L. M. Shelton, T. Ooga, G. Mackay,
N. Van Den Broek, J. R. Bertino, A. Vazquez, Quantification of folate metabolism using
transient metabolic flux analysis. Cancer Metab. 3, 6 (2015).
22. G. P. Morrow, L. MacMillan, S. G. Lamarre, S. K. Young, A. J. MacFarlane, M. E. Brosnan,
J. T. Brosnan, In vivo kinetics of formate metabolism in folate-deficient and folate-replete
rats. J. Biol. Chem. 290, 2244–2250 (2015).
23. H. R. Bridges, A. J. Y. Jones, M. N. Pollak, J. Hirst, Effects of metformin and other
biguanides on oxidative phosphorylation in mitochondria. Biochem. J. 462, 475–487
(2014).
24. S.-P. Gravel, L. Hulea, N. Toban, E. Birman, M.-J. Blouin, M. Zakikhani, Y. Zhao, I. Topisirovic,
J. St-Pierre, M. Pollak, Serine deprivation enhances antineoplastic activity of biguanides.
Cancer Res. 74, 7521–7533 (2014).
25. O. Warburg, On the origin of cancer cells. Science 123, 309–314 (1956).
26. A. Vazquez, J. Liu, Y. Zhou, Z. N. Oltvai, Catabolic efficiency of aerobic glycolysis:
The Warburg effect revisited. BMC Syst. Biol. 4, 58 (2010).
27. F. Patella, Z. T. Schug, E. Persi, L. J. Neilson, Z. Erami, D. Avanzato, F. Maione,
J. R. Hernandez-Fernaud, G. Mackay, L. Zheng, S. Reid, C. Frezza, E. Giraudo, A. Fiorio Pla,
K. Anderson, E. Ruppin, E. Gottlieb, S. Zanivan, Proteomics-based metabolic modeling
reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability.
Mol. Cell. Proteomics 14, 621–634 (2015).
28. R. Fodde, R. Smits, H. Clevers, APC, signal transduction and genetic instability in colorectal
cancer. Nat. Rev. Cancer 1, 55–67 (2001).
29. S. C. Dolfi, L. L.-Y. Chan, J. Qiu, P. M. Tedeschi, J. R. Bertino, K. M. Hirshfield, Z. N. Oltvai,
A. Vazquez, The metabolic demands of cancer cells are coupled to their size and
protein synthesis rates. Cancer Metab. 1, 20 (2013).
30. J. Fan, J. B. Ye, J. J. Kamphorst, T. Shlomi, C. B. Thompson, J. D. Rabinowitz, Quantitative
flux analysis reveals folate-dependent NADPH production. Nature 510, 298–302 (2014).
31. J. H. Yang, A. Wada, K. Yoshida, Y. Miyoshi, T. Sayano, K. Esaki, M. O. Kinoshita,
S. Tomonaga, N. Azuma, M. Watanabe, K. Hamase, K. Zaitsu, T. Machida, A. Messing,
S. Itohara, Y. Hirabayashi, S. Furuya, Brain-specific Phgdh deletion reveals a pivotal role for
L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate
receptor co-agonist, in adult brain. J. Biol. Chem. 285, 41380–41390 (2010).
Acknowledgments: We acknowledge the Cancer Research U.K. Glasgow Centre (C596/
A18076) and the Biological Services Unit (BSU) facilities at the Cancer Research U.K.
Beatson Institute (C596/A17196). Funding: This work was supported by the Cancer Research
U.K. grant no. C596/A21140. J.M. was supported by a Deutsche Forschungsgemeinschaft
Fellowship grant no. ME 4636/2-1. Author contributions: J.M. performed all in vitro
experiments and analyzed data. S.T. and J.J.K. developed the GC-MS method for formate.
O.M., C.F.L., and K.V. conceived mice serine starvation experiments. D.A. and K.B. performed
in vivo mice serine starvation experiments and in vivo 13C serine tracing. N.V.D.B. and
G.M.M. measured LC-MS samples and developed analysis methods. E.G. provided guidance.
A.V. developed software algorithms for data analysis and analyzed data. J.M. and A.V. designed
experiments and wrote the manuscript. All authors read the manuscript. Competing
interests: The authors declare that they have no competing interests. Data and materials
availability: All data needed to evaluate the conclusions in the paper are present in
the paper and/or the Supplementary Materials. Additional data related to this paper
may be requested from the authors.
Submitted 6 June 2016
Accepted 27 September 2016
Published 28 October 2016
10.1126/sciadv.1601273
Citation: J. Meiser, S. Tumanov, O. Maddocks, C. F. Labuschagne, D. Athineos, N. Van Den Broek,
G. M. Mackay, E. Gottlieb, K. Blyth, K. Vousden, J. J. Kamphorst, A. Vazquez, Serine one-carbon
catabolism with formate overflow. Sci. Adv. 2, e1601273 (2016).10 of 10
doi: 10.1126/sciadv.1601273
2016, 2:.Sci Adv 
Kamphorst and Alexei Vazquez (October 28, 2016)
M. Mackay, Eyal Gottlieb, Karen Blyth, Karen Vousden, Jurre J. 
GillianFred Labuschagne, Dimitris Athineos, Niels Van Den Broek, 
Johannes Meiser, Sergey Tumanov, Oliver Maddocks, Christiaan
Serine one-carbon catabolism with formate overflow
this article is published is noted on the first page. 
This article is publisher under a Creative Commons license. The specific license under which
article, including for commercial purposes, provided you give proper attribution.
licenses, you may freely distribute, adapt, or reuse theCC BY For articles published under 
. here
Association for the Advancement of Science (AAAS). You may request permission by clicking 
for non-commerical purposes. Commercial use requires prior permission from the American 
licenses, you may distribute, adapt, or reuse the articleCC BY-NC For articles published under 
http://advances.sciencemag.org. (This information is current as of April 13, 2017):
The following resources related to this article are available online at
http://advances.sciencemag.org/content/2/10/e1601273.full
online version of this article at: 
 including high-resolution figures, can be found in theUpdated information and services,
http://advances.sciencemag.org/content/suppl/2016/10/24/2.10.e1601273.DC1
 can be found at: Supporting Online Material
http://advances.sciencemag.org/content/2/10/e1601273#BIBL
 9 of which you can access for free at: cites 28 articles,This article 
trademark of AAAS 
otherwise. AAAS is the exclusive licensee. The title Science Advances is a registered 
York Avenue NW, Washington, DC 20005. Copyright is held by the Authors unless stated
published by the American Association for the Advancement of Science (AAAS), 1200 New 
 (ISSN 2375-2548) publishes new articles weekly. The journal isScience Advances
 o
n
 April 13, 2017
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
